Form 8-K - Current report:
SEC Accession No. 0001127537-21-000045
Filing Date
2021-11-02
Accepted
2021-11-02 16:05:52
Documents
14
Period of Report
2021-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lung-20211102.htm   iXBRL 8-K 38267
2 EX-99.1 lung3q21earningsrelease.htm EX-99.1 125320
6 pulmonxlogoa.jpg GRAPHIC 8517
  Complete submission text file 0001127537-21-000045.txt   329590

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lung-20211102.xsd EX-101.SCH 1924
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lung-20211102_lab.xml EX-101.LAB 24975
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lung-20211102_pre.xml EX-101.PRE 13197
7 EXTRACTED XBRL INSTANCE DOCUMENT lung-20211102_htm.xml XML 12009
Mailing Address 700 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 700 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-364-0400
Pulmonx Corp (Filer) CIK: 0001127537 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39562 | Film No.: 211371224
SIC: 3841 Surgical & Medical Instruments & Apparatus